2nd Quarter - Report

WATKINS & EAGER PLLC for ZYNERBA PHARMACEUTICALS, INC.

Firm
Client
Income
$45,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Encourage Members to act favorably on matters of importance to Zynerba at their direction; Trial for medication that could help individuals with Fragile X Syndrome.

LobbyistCovered position, as disclosed
GREGG L HARPER Former Member of U.S. House of Representatives

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Government Issues GOV

Encourage Members to act favorably on matters of importance to Zynerba at their direction; Trial for medication that could help individuals with Fragile X Syndrome.

LobbyistCovered position, as disclosed
GREGG L HARPER Former Member of U.S. House of Representatives

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Encourage Members to act favorably on matters of importance to Zynerba at their direction; Trial for medication that could help individuals with Fragile X Syndrome.

LobbyistCovered position, as disclosed
GREGG L HARPER Former Member of U.S. House of Representatives

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.